Hyloris Celebrates Valacyclovir FDA Filing Amid Series Of Announcements
The Belgian Player Disclosed Three New Deals Through February
Following steady updates on its development of a new formulation of valacyclovir, Hyloris revealed the US FDA’s acceptance of its NDA filing while also announcing three new deals this month.
